Skip to content

Public FDA record

Z-1080-04: FDP Plasma kit provides reagents for the detection and semi-quantitation of fibrin/fibrinogen degradation

Recall record Z-1080-04 for Diagnostica Stago, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1080-04
Company in FDA record
Diagnostica Stago, Inc.
FDA classification date
Jul 20, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The FDP Plasma latex reagent (Reagent Vial 1) is more sensitive which may result in a weak agglutination at low concentration of FDPs.

Source facts

Action
Diagnostica Stago sent a letter dated 12/4/2002 along with effectiveness check form to all customers.
Initiated
2002-12-04
Root cause
Other
Terminated
2004-07-14
Distribution
The firm distributed the product 220 direct accounts which include hospitals, clinics, and clinical laboratories. There are 9 VA accounts.
Recall number
Z-1080-04
Recall status
Terminated
CDRH record ID
33267
FDA classified
2004-07-20
Recall event number
29178

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗